-
April 09, 2013
Five Japanese pharmaceutical companies have joined a public-private partnership with the government of Japan and the Bill & Melinda Gates Foundation to advance research and development of new medicines, vaccines and diagnostics targeting infectious diseases in the developing world.
Full story
-
June 14, 2012
Japan’s Astellas Pharma has signed an agreement with the Drugs for Neglected Diseases initiative (DNDi) to collaborate on drug discovery research for three neglected tropical diseases: leishmaniasis, Chagas disease and sleeping sickness.
Full story
-
March 08, 2012
The Drug Discovery Unit (DDU) at Scotland’s Dundee University has secured more than £10 million from the Wellcome Trust to research and develop safe and affordable treatments for neglected tropical diseases, including £8.6 million for a partnership between the university and GlaxoSmithKline (GSK).
Full story
-
January 30, 2012
Thirteen pharmaceutical companies, along with governments and other health organisations have unveiled what they call "a coordinated push to accelerate progress toward eliminating or controlling ten neglected tropical diseases by the end of the decade"
Full story
-
October 27, 2011
Some of the world's biggest drugmakers have joined forces with the UN's' World Intellectual Property Organisation to set up a consortium to share patent information with researchers looking to develop treatments for neglected disease
Full story
-
June 02, 2011
Sanofi has deepened its relationship with the Geneva-based Drugs for Neglected Diseases initiative (DNDi), entering into a three-year collaboration agreement with DNDi for research into new treatments for nine neglected tropical diseases.
Full story